目的:研究肺癌组织中Nrf2、Keap1和NQO1蛋白表达的情况。方法:采用免疫组化法检测67例肺癌患者的肺癌组织及癌旁正常组织中Nrf2、Keap1和NQO1蛋白的表达,并分析Keap1、Nrf2和NQO1蛋白的表达与肺癌临床病理特征的关系。结果:Keap1蛋白在肺Ⅰ、Ⅱ、Ⅲ期鳞癌和Ⅲ期、Ⅳ期腺癌中的表达高于癌旁正常组织(P〈0.05);Nrf2蛋白在肺Ⅰ期鳞癌和Ⅱ、Ⅲ、Ⅳ期腺癌中的表达低于癌旁正常组织(P〈0.05);NQO1蛋白在肺Ⅰ期鳞癌中的表达低于癌旁正常组织(P〈0.05),在Ⅱ期腺癌中的表达高于癌旁正常组织(P〈0.05)。3种蛋白的表达与肺癌患者的临床分期和是否侵及胸膜有关(P〈0.05)。结论:肺癌组织中Keap1、Nrf2、NQO1蛋白表达异常,提示Keap1-Nrf2/ARE通路在肺癌的发生发展中可能发挥重要的作用。
Aim:To study the protein expressions of Nrf2,Keap1 and NQO1 in lung cancer tissue.Methods:Immunohistochemistry was applied to detect the protein expressions of Keap1,Nrf2 and NQO1 in 67 cases of lung cancer tissue and adjacent normal tissue.Results:The protein expression of Keap1 was significantly higher in human phaseⅠ,Ⅱ and Ⅲ lung squamous cell carcinoma and phase Ⅲ and Ⅳ lung adenocarcinoma than normal tissue(P 〈 0.05).The protein expression of Nrf2 was significantly lower in human phaseⅠlung squamous cell carcinoma and phase Ⅱ,Ⅲ and Ⅳ lung adenocarcinoma than normal tissue(P 〈 0.05).The protein expression of NQO1 was significantly lower in human phaseⅠlung squamous cell carcinoma and was significantly higher in human phase Ⅱ lung adenocarcinoma than normal tissue(P 〈 0.05).The protein expressions of Keap1,NQO1 and Nrf2 were related with clinical classification and distant metastasis(P 〈 0.05).Conclusion:The abnormal expressions of Keap1,Nrf2,and NQO1 in lung cancer indicate that Keap1-Nrf2 /ARE pathway may play an important role in lung cancer initiation and promotion.